|
RESIDENT
CASE
STUDIES
Week 11 June 28 - July 4, 2003: Case 1
Table
of Contents | List of Diagnoses | Case 1 |
Case 2
| Case 3
32
year old male with right knee mass that is negative for actin, desmin, and
Myo D1 with no SSX/SSY translocation
Discussion
Epithelioid sarcoma (ES) is a distinct tumor of unknown lineage affecting
mainly adolescents and young adults. It is rare in infants and the
elderly. It may be misdiagnosed as a benign lesion especially benign
granulomatous process.1 The most commonly affected areas are
the flexor surface of fingers, hand, wrist and forearm. It may be
superficial or deep-seated. The trunk, head and neck regions are seldom
involved by classical epithelioid sarcoma.1 When superficial it
usually presents as firm, slow growing, painless solitary or multiple
nodules/plaque-like lesions. There
may be ulceration of the skin. Deep-seated
lesions are often attached to tendons, tendon or aponeurosis.1
The size may range from a few millimeters to several centimeters,
(especially in deep seated tumors).
Histologically, the classic ES
shows a characteristic nodular growth pattern frequently (but not always)
with central necrosis (geographic necrosis), simulating benign necrobiotic processes such as rheumatoid nodule and
granuloma annulare. The typical nodule is composed of a mixed
proliferation of eosinophilic epithelioid and spindle cells with nuclear
atypia, vesicular nuclei and small nucleoli.1 The
number of mitoses is usually low--often less than 5/hpf. The cells can
have rhabdoid features.1 ES
is characteristically immunoreactive for vimentin and epithelial markers
(e.g. LMK, HMK, EMA, CK8 and CK19).1,2 Half of the cases
are reported positive for CD34,2
and occasional reactivity for muscle specific actins, NSE and S100 have
been reported.2
ES is an aggressive sarcoma
with high recurrence rate3 with an overall recurrence rate of
80% at 10 years.4
Adverse
prognostic factors in ES include
male sex, advanced age at diagnosis, large tumor size (>5cm), deep
location, nuclear pleomorphism, high mitotic activity, presence of
vascular and or nerve invasion, multiple recurrence, presence of lymph
node metastasis at diagnosis.1
References: 1Fletcher
CDM, Unni KK, Mertens F. (Eds.): World Health Organization Classification
of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone.
IARC Press: Lyon 2002.
2Miettinen M,
Fanburg-Smith JC, Virolainen M, et al. Epithelioid sarcoma: an
immunohistochemical analysis of 112 classical and variant cases and a
discussion of the differential diagnosis. Hum Pathol 1999;30:934-942.
3Halling AC,
Wollan PC, Pritchard DJ, et al. Epithelioid sarcoma: a clinicopathologic
review of 55 cases. Mayo Clin Proc 1996;71:636-642.
4Chase DR. Do
“rhabdoid features“ impart a poorer prognosis to proximal-type
epithelioid sarcoma? Adv Ana Pathol 1997;4:293-299.
|